FENNEC PHARMACEUTICALS INC (FRX.CA) Stock Income Statement
Canada - TSX:FRX - CA31447P1009 - Common Stock
11.59 CAD
-0.65 (-5.31%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.30M | 47.54M | 21.25M | 1.54M | 0.00 | |||
| Cost Of Goods | 3.37M | 3.18M | 1.26M | 90.00K | N/A | |||
| Gross Profit | 29.94M | 44.35M | 19.99M | 1.45M | N/A | |||
| Operating Expenses | 39.05M | 41.82M | 32.74M | 24.03M | 17.22M | |||
| Research and Development | 348.00K | 307.00K | 56.00K | 3.53M | 4.98M | |||
| Selling, General, and Administrative Expenses | 39.23M | 41.00M | 33.00M | 20.51M | 12.24M | |||
| Operating Income | -9.67M | 2.57M | -13.00M | -22.59M | -17.22M | |||
| Interest Income/Expense | -2.00M | -2.64M | -3.27M | -1.13M | -120.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -11.68M | -70.00K | -16.00M | -23.71M | -17.35M | |||
| Income Tax | N/A | 370.00K | N/A | N/A | N/A | |||
| Net Income | -12.05M | -440.00K | -16.00M | -23.71M | -17.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.43 | -0.02 | -0.60 | -0.90 | -0.67 | |||
| Non GAAP EPS | -0.42 | -0.00 | -0.61 | -0.90 | -0.67 | |||
| Statistics | ||||||||
| Gross Profit Margin | 89.89% | 93.30% | 94.08% | 94.16% | N/A | |||
| Profit Margin | -36.18% | -0.93% | -75.29% | -1539.61% | N/A | |||
| Operating Profit Margin | -29.04% | 5.41% | -61.17% | -1466.88% | N/A | |||
All data in USD